AGM/EGMMay 5, 2026, 04:52 PM
West Pharma Shareholders Elect Directors, Approve Exec Comp & Auditor
AI Summary
West Pharmaceutical Services, Inc. held its 2026 Annual Meeting of Shareholders virtually on May 4, 2026. Shareholders elected eleven director nominees, approved the non-binding advisory vote on executive compensation, and ratified PricewaterhouseCoopers LLP as the independent auditor for the 2026 fiscal year. Additionally, a shareholder proposal for an Independent Board Chair Policy was not approved.
Key Highlights
- Eleven director nominees were elected to serve until the 2027 Annual Meeting of Shareholders.
- The non-binding advisory vote to approve executive compensation was approved with 60,107,802 votes For.
- PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for 2026 with 58,509,119 votes For.
- A shareholder proposal regarding an Independent Board Chair Policy was not approved, receiving 34,245,125 votes Against.
- A total of 66,193,322 shares, representing 91.83% of common stock outstanding, were represented at the meeting.
Price Impact
More from WST